02.08.2023 13:52:53
|
Karyopharm Therapeutics Inc. Q2 Loss decreases, beats estimates
(RTTNews) - Karyopharm Therapeutics Inc. (KPTI) reported Loss for second quarter that decreased from last year and beat the Street estimates.
The company's earnings totaled -$32.630 million, or -$0.29 per share. This compares with -$49.062 million, or -$0.62 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 5.3% to $37.579 million from $39.679 million last year.
Karyopharm Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$32.630 Mln. vs. -$49.062 Mln. last year. -EPS (Q2): -$0.29 vs. -$0.62 last year. -Analyst Estimates: -$0.34 -Revenue (Q2): $37.579 Mln vs. $39.679 Mln last year.
-Guidance: Full year revenue guidance: $145 to $160 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Karyopharm Therapeutics Incmehr Nachrichten
18.02.25 |
Ausblick: Karyopharm Therapeutics präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
04.11.24 |
Ausblick: Karyopharm Therapeutics verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Karyopharm Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Karyopharm Therapeutics Inc | 0,54 | -3,27% |
|